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Background: To investigate the effect of HBV markers on HBV-GN.
Methods: The immunohistochemistry was used to detect HBsAg and HBcAg in frozen sections of renal biopsy, the
changes in HBV serum markers, renal functional parameters and clinical manifestations or symptoms were observed
to analyze renal damage.
Results: Using renal biopsy data from 329 cases, this study found that the most common pathological subtype in
HBV-GN was mesangioproliferative glomerulonephritis (MsPGN) (24.9%, P <0.05), and 29.4% of patients who show
serological HBsAg, HBeAg and anti-HBc positive developed membranoproliferative glomerulonephritis (MPGN)
(P <0.05). The immunohistochemistry was used to detect HBsAg and HBcAg in frozen sections.50% of HBsAg and
HBcAg deposits was observed in the glomeruli of MPGN patients, while 36.6% of HBsAg and 43.9% of HBcAg
deposited in the glomeruli of MsPGN patients. The deposits of HBsAg and HBcAg in glomeruli were directly
correlated with IgA, IgG, IgM and C3 deposits. In addition, cases with a moderate to severe decrease as reflected by
the glomerular filtration rate (GFR) were predominantly patients with MPGN (31.6%, P <0.05) or MsPGN (21.1%,
P <0.05). Patients who were serological HBsAg, HBeAg and anti-HBc positive or HBsAg, anti-HBe and anti-HBc
positive mainly exhibited urine and renal parameter changes.
Conclusion: Examination of HBV markers in serum and renal biopsy will be useful for clinicians to predict the renal
damage in early stage when it is reversible in HBV-GN.
Keywords: HBV serum markers, Pathological subtype of hepatitis B virus-associated glomerulonephritis,
Renal functional parameters, Clinical manifestations or symptomsBackground
Hepatitis B virus (HBV) infection occurs worldwide, with
a high prevalence in most developing countries in South-
east Asia and Africa. Extra-hepatic manifestations of
HBV infection are being increasingly recognized, with an
expanding prevalence. One of the most common mani-
festations is HBV-GN [1,2]. Different pathological types
of glomerular lesions have been described in association
with HBV infection, including pathological patterns such* Correspondence: jinxm55@yahoo.com.cn
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reproduction in any medium, provided the oras MPGN, MsPGN, and Membranoproliferative glomer-
ulonephritis (MN). MPGN is a chronic progressive glom-
erulonephritis that is common in young and middle-aged
adults, and is characterized by an increase in mesangial
cellularity and matrix, with thickening of glomerular ca-
pillary walls secondary to subendothelial and mesangial
deposition of circulating immune complexes and/or
complement factors, cellular entrapment, and new base-
ment membrane formation. It is always present in neph-
rotic syndrome or acute nephritic syndrome [3]. MPGN
has a poorer prognosis than MN and is associated with
a high risk of renal failure. MsPGN is common in
teenagers and demonstrates mesangial hypercellularityLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.








MsPGN 82 (24.9*) 476 (15.2)
MPGN 64 (19.5) 254 (8.1)
MN 38 (11.6) 650 (20.7)
MCG 31 (9.4) 296 (9.4)
GML 30 (9.1) 501 (16.0)
IgAN 51 (15.5) 669 (21.3)
other 33 (10) 290 (9.24)
Total 329 3136
*P < 0.05.
Abbreviations: MsPGN, Mesangioproliferative glomerulonephritis; MPGN,
Membranoproliferative glomerulonephritis; MN, Membranous Nephropathy;
MCG, Minimal change glomerulopathy; GML, Glomerular minor lesion; IgAN,
IgA Nephropathy.
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festation and prognosis of moderate-severe MsPGN are
similar to those of MPGN. MN is a chronic progressive
glomerulonephritis that is common in adults, character-
ized by sub-epithelial immune deposits inducing non-
selective proteinuria. However, among these histological
types, MN has been reported as the commonest patho-
logical type of HBV-GN in Hong Kong and South Africa
[5-7], compared to IgA nephropathy followed by MN in
Thailand [8] and MN and MPGN in Japanese adults [9].
HBV infection is prevalent in China, and HBV-GN com-
monly causes renal damage secondary to HBV infection.
At present, there are no definite diagnostic criteria for
HBV-GN. However, the reference diagnostic criteria used
in China are as follows [10]: a) HBsAg-positive serum; b)
presence of glomerular nephritis, excluding lupus neph-
ritis and other secondary glomerular diseases; and c) HBV
antigens including HBsAg or HBcAg, or HBV DNA mea-
sured by PCR in nephridial tissue. Among these criteria,
the third criterion is required for a final diagnosis. In our
study, for serum HBsAg-positive patients, including
HBsAg-, HBeAg- and anti-HBc-positive patients; HBsAg-,
anti-HBe- and anti-HBc-positive patients; HBsAg- and
anti-HBc-positive patients; and simple HBsAg-positive
patients, it is of great clinical significance to analyse the
degree of HBV antigen deposited in renal tissue and the
glomerular impairment. These different serum markers of
HBV are an indirectly measure of the injury and prognosis
of HBV-GN. The present study summarised and analysed
the changes in HBV serum markers, renal functional para-
meters, clinical manifestations or symptoms and the
pathological data and of 329 clinical cases of HBV-GN
from Harbin in northeastern China.
Methods
The clinical data
A total of 329 cases from among 5250 patients (329/5250,
6.27%), who underwent renal biopsies and were diagnosed
as HBV-GN with HBsAg-positive serum, were analysed in
this study. Diagnoses were made by the Department of
Pathology, Harbin Medical University, from January 1998
to April 2010. There were 221 males and 108 females,
with a male-to-female ratio of 2.05:1. All patients were
between 17 years old and 63 years old with, an average
age of 33.28 ± 9.45 years. 3136 cases from 5250 patients
(3136/5250, 59.7%) with HBsAg-negative serum were
taken as negative control. Negative control was selected
and matched for gender and age distribution (average
age of 33 ± 14 years and male-to-female ratio of 1.97:1).
The pathological classification and the diagnosis criteria
The lesions of the 329 cases of glomerular nephritis were
classified according to the 1990 WHO Classification cri-
teria [11]. The diagnosis of nephropathy was confirmed bypathology. Sections from all biopsy specimens also were
stained routinely with hematoxylin and eosin (H&E), peri-
odic acid-sliver methenamine (PASM), Masson’s tri-
chrome, and antibodies against IgA, IgG, IgM and the C3
complement component. Fluorescently labelled goat anti-
human IgA (alpha) was purchased from KPL (Kirkegaard
& Perry Laboratories, Inc. US). FITC-labelled mouse anti-
human IgG1 (Fc) and FITC-labelled goat anti-human IgM
were purchased from Abcam Limited (Cambridgeshire,
UK). FITC-labelled rabbit anti-human C3c antibody was
purchased from Dako (Dako A/S, Glostrup, Denmark).HBsAg and HBcAg were detected in frozen and paraffin
section with immunohistochemical method
Frozen slices from biopsies of the 329 cases were kept in a
low-temperature freezer. Monoclonal anti-human-HBsAg,
anti-human-HBcAg and goat anti-mouse antibodies were
purchased from Zhongshan Goldenbridge Biotechnology
Co., Ltd. HBsAg and HBcAg were detected with immuno-
histochemical method in frozen and paraffin sections.The renal function staging, urine and renal parameters
The renal function was staged as CKD I-V according to
the American standard stages of renal function [12]. The
staging is based on the degree to which glomerular fil-
tration rate (GFR) is reduced. The value of the GFR was
calculated, adjusting for the creatinine level, age and
body weight. The higher the level of GFR was, the more
effectivity for the kidney can remove toxins. The GFR
was divided into five categories: I: normal or increased
GFR with renal damage, GFR > 90; II: mild decrease in
the GFR with renal damage, GFR: 60–89; III: moderate
decrease in the GFR, GFR: 30–59; IV: severe decrease in
the GFR, GFR: 15–29; and V: renal failure, GFR < 15 or
dialysis. Changes in routinely determined urine and
Table 2 Clinical significance of HBV-positive patient serum (N=329)
HBV-infectious markers in serum Number (%) Clinical significance
HBsAg HBsAb HBeAg HBeAb HBcAb
+ − + − + 160 (48.6) * acute, chronic type B hepatitis, highly contagious
+ − − + + 89 (27.1) * acute, chronic type B hepatitis, contagious
+ − − − + 47 (14.3) acute, chronic type B hepatitis, contagious
+ − − − − 33 (10) acute infection, incubation at a later period
*P < 0.05.
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nitrogen (BUN) and serum creatinine (Scr) levels were
documented. The concentration of protein in the urine
was quantitatively detected using the sulphosalicylic acid
method. The level of urine protein was graded semi-
quantitatively on a negative to 4+ scales. The serum
HBV markers and pathological subtypes of patients with
high BUN and Scr levels were analysed.
Ethics approval was obtained from the ethical commit-
tee of Harbin Medical University, China.
Statistical analysis
Statistical analysis was performed using SAS version
9.1 software (SAS Institute Inc., Cary, NC, USA).
Comparisons of categorical data were performed using
the chi-square test, with P < 0.05 being considered sta-
tistically significant.
Results
The relationship between different serum markers for
HBV in 329 cases and the clinical and pathological typing
of HBV-GN
Among the 329 cases of HBV-GN, there were many
types of primary glomerulonephritis; however, MsPGN
was the most common type (82/329, 24.9%, P< 0.05).
The second most common type of HBV-GN was MPGN
(64/329, 19.5%) followed by IgA nephropathy (IgAN).
But IgAN (669/3136, 21.3%), MN (650/3136, 20.7%),
GML (501/3136, 16%) and MsPGN (470/3136, 15.2%)
were the major types in the negative control (Table 1).
Different HBV-infection markers in serum are used to
judge the severity of an infection and reflect the replica-
tion of HBV in clinical practice (Table 2). The frequency





HBsAg+,HBeAg+,HBcAb+ 160 37(23.1) * 47(29.4) *
HBsAg+,HBeAb+,HBcAb+ 89 26(29.2) * 10(11.2)
HBsAg+,HBcAb+ 47 11(23.4) 4(8.5)
HBsAg+ 33 8(24.2) 3(9.1)
*P < 0.05.positivity was 48.6% (P< 0.05), and 27.1% of the 329
cases were HBsAg, anti-HBe and anti-HBc positive
(P< 0.05). These results indicate that the damage to the
glomeruli was severe when patients had serious HBV
infections.
The most common pathological type of patients positive
for HBsAg, HBeAg and anti-HBc was MPGN (47/160,
29.4%, P< 0.05); MsPGN was observed in patients who
were HBsAg, HBeAg and anti-HBc positive and in those
who were HBsAg, anti-HBe and anti-HBc positive 37/160
(23.1%, P< 0.05); and 26/89 (29.2%, P< 0.05), respectively
(Table 3, Figure 1).The characteristics of HBsAg and HBcAg deposits in the
glomeruli of patients with HBV-GN
HBsAg and HBcAg were detected in frozen renal biopsy
sections from the 329 cases of HBV-GN. HBsAg and
HBcAg were deposited in the mesangial region and in
the capillary walls of glomeruli (Figures 2C, D, E, F) but
not in renal tubules or in the interstitium. However, in
paraffin-embedded sections, weak expression of HBsAg
and HBcAg was detected mostly in the proximal convo-
luted tubules of glomeruli, data not shown. The present
study was thus focused on the immunohistochemistry of
the frozen slices. The results from the frozen sections
showed a 50% expression rate of HBsAg and HBcAg in
the glomeruli of patients with MPGN (P < 0.05) and
36.6% and 43.9% expression rates, respectively, for
MsPGN (P < 0.05) (Table 4).
The relationship between the serum HBV-infection
markers, age, initial symptoms, changes in routine urine
and renal parameters and the stage of renal function in
the 329 patients with HBV-GN.ers in 329 cases and the pathological subtype of HBV-GN
thological subtype of HBV-GN, number (%)
MN MCG GML IgAN Other
16(10) 9(5.6) 13(8.1) 23(14.4) 15(9.4)
9(10.1) 8(9) 11(12.4) 16(18) 9(10.1)
9(19.2) 6(12.8) 1(2.1) 9(19.2) 7(14.9)
4(12.1) 8(24.2) 5(15.2) 3(9.1) 2(6.1)
Figure 1 The relationship between hepatitis serum markers
and the pathological type of HBV-GN of 329 cases. The
pathological type of patients positive for HBsAg, HBeAg and
Anti-HBc was most frequently MPGN (33.6%, p < 0.05), followed
by MsPGN (24.1%, p < 0.05). MsPGN:Mesangioproliferative
glomerulonephritis; MPGN: Membranoproliferative glomerulonephritis;
MN: Membranous Nephropathy; MCG: Minimal change
glomerulopathy; GML: Glomerular minor lesion; IgAN: IgA
Nephropathy.
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cidence of HBV-GN, with a peak at 30 to 40 years
(Figure 3A). The most common initial symptom was
edema (Figure 3B). Past medical history included hepa-
titis lasting from several months to several decades.Figure 2 The HBsAg and HBcAg levels in glomeruli in frozen biopsy s
glomerulus and tublules in glomeruli of HBsAg-negetive cases (G indicates
HBsAg present in glomeruli. SP × 120 and SP× 460. 2E, 2 F (the magnificatiThe relationship between the serum HBV infection
markers of 329 cases and the staging of renal function
revealed that most patients were in stage I. The per-
centage of patients with glomerular damage resulting
from HBV infection was 68.4% (225/329) among stage
I patients. In addition, a moderate-severe decrease in
the GFR (including stages III,IVand V)to renal function
failure was observed in 11.6% (38/329) (Tables 5, 6,
Figure 4); however, among the 38 cases, the patho-
logical type was MPGN in 12 cases (12/38, 31.6%,
P < 0.05) and MsPGN in 8 cases (8/38, 21.1%, P < 0.05).
Together, patients with MPGN and MsPGN (20/38,
52.6%, P < 0.05) were at a high risk of renal failure,
with an unfavourable prognosis (Table 7). The quanti-
tative detection of urine protein revealed that renal
function was easily damaged in patients with MPGN
and MsPGN (Figure 5A), and patients with HBsAg-,
HBeAg- and anti-HBc-positive serum or HBsAg-, anti-
HBe- and anti-HBc-positive serum were likely to have
high levels of protein in the urine (Figure 5B). The
most common pathological subtypes of patients with
elevated BUN and Scr levels were MsPGN and MPGN
(Figure 5C, P < 0.05).lices. 2A, 2B (the magnification of 2A): HBsAg was not present in the
a glomerulus). SP × 120 and SP × 460 2C, 2D (the magnification of 2C):
on of 2E): HBcAg present in the glomeruli. SP × 120 and SP× 460.
Table 4 The expression of HBsAg and HBcAg in glomeruli from different pathological subtypes of HBV-GN
The pathological subtype Number HBsAg number (%) HBcAb number (%)
+ - + -
MsPGN 82 30(36.6)* 52(63.4) 36(43.9)* 46(56.1)
MPGN 64 32(50)* 32(50) 32(50)* 32(50)
MN 38 14(36.8) 24(63.2) 23(60.5) 15(39.5)
MCG 31 22(71) 9(29) 16(51.6) 15(48.4)
GML 30 12(40) 18(60) 13(43.3) 17(56.7)
IgAN 51 12(23.5) 39(76.5) 12(23.5) 39(76.5)
other 33 14(42.4) 19(57.6) 11(33.3) 22(66. 7)
total 329 136(41.3) 193(58.7) 143(43.5) 186(56.5)
*P < 0.05.
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glomeruli and the types of Ig and complement deposits
HBsAg and HBcAg were deposited in the glomeruli of
patients with HBV-GN along with the following Ig types
and the following complement components. IgA depos-
ition reached 73% (89/122), C3 deposition reached
68.9% (84/122), IgG deposition reached 78.7% (96/122),
and IgM deposition reached 47.5% (58/122). The fre-
quency of IgA deposition in patients with HBV-GN was
highest in those who only expressed HBcAg in glomeruli
(49/64, 76.6%), but this difference was not statistically
significant (Table 8).
Discussion
Chronic hepatitis B and asymptomatic carriage of HBV is
associated with HBV-GN [13]. Patients with HBV-GN
have a high morbidity rate. In general, the clinical mani-
festations are not specific, and the hepatic and renal
functions are normal for several years. The initial symp-
toms detected in medical examinations are usually pro-
teinuria and hematuria. By this time, the renal damage is
severe and irreversible. Important laboratory examina-
tions include the evaluation of serum HBV markers,
changes in renal hemodynamics and a pathological
examination including a renal biopsy. These examina-
tions are important for early diagnosis and treatment.Figure 3 Ages and initial symptoms of the 329 patients with HBV-GN
of the 329 cases of HBV-GN.Some studies have investigated the relationship be-
tween HBV infection and IgA nephropathy. Lai et al.
found that the morbidity due to IgA nephropathy was
high in an area of high HBV prevalence. The frequency
of HBsAg-positivity in IgAN serum was higher than that
in healthy control serum. HBsAg, HBcAg and the corre-
sponding immune complexes were deposited in the
glomeruli. Furthermore, the deposit site was the same as
that of IgA. This finding is notable because HBV and its
immune complexes deposited in the glomeruli play a
major role in the pathogenesis of IgAN [14]. The above
mentioned studies give a hint at the close relationship
between HBV infection and renal damage. HBV can in-
volve the kidney as well as the liver, and renal function
must thus be monitored in HBV-infected patients [15].
Thus, when the damage of HBV is evaluated, doctors
need to focus on the change in hepatic function and to
monitor the renal function index. The renal damage is
related to virus replication and, more importantly, is
linked to the immune response [16]. Chronic HBV infec-
tion can induce renal damage, and antigen-antibody im-
mune complexes against HBs, HBc, or HBe together
with complement components have been demonstrated
to induce renal damage [17].
In the present study, the detection of HBsAg and
HBcAg along with the expression of Ig types and the. 3A: Age distribution of the 329 cases of HBV-GN. 3B: Initial symptoms
Table 5 The relationship between serum HBV-infectious markers in 329 cases, and initial symptoms and the staging of
renal function in HBV-GN
HBV-infectious
markers in serum
Initial symptoms number (%) Renal function staging, number(%)
N Edema Urine abnormity Lumbago and hypodynamia I II III IV V
HBsAg+,HBeAg+,HBcAb+ 160 84(52.5) 49(30.6) 27(16.9) 110(68.8) 35(21.9) 12(7.5) 2(1.3) 1(0.6)
HBsAg+,HBeAb+,HBcAb+ 89 45(50.6) 26(29.2) 18(20.2) 61(68.5) 15(16.9) 6(6.7) 3(3.4) 4(4.5)
HBsAg+,HBcAb+ 47 24(51.1) 11(23.4) 12(25.5) 27(57.5) 13(27.7) 3(6.4) 4(8.5) 0
HBsAg+ 33 16(48.5) 10(30.3) 7(21.2) 27(81.8) 3(9.1) 2(6.1) 1(3) 0
Total 329 169(51.4) 96(29.2) 64(19.5) 225(68.4) 66(20.1) 23(7) 10(3) 5(1.5)
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deposits suggests that an immune complex mechanism
leads to glomerular injury. The antigen-antibody com-
plex in renal tissues is mainly derived from blood circu-
lation, and the circulating immune complex is detained
passively in the glomeruli. The immune complex
damages the kidney by activating the complement sys-
tem and cytokines, which is one of the major mechan-
isms of the pathogenesis of HBV-GN. Jiang W [18]
suggested that these autoimmunity factors may play a
role in the morbidity of HBV-GN. HBcAg in renal tissue
as a target antigen can initiate cytotoxic T-cell-linked
immunologic injury in renal tubular epithelial cells. The
pathogenesis of HBV-GN is closely related to the im-
mune state in human, and the damage of cells after
HBV infection is provoked by the immune response in
the host. If a patient’s immune system is inadequate, the
virus cannot be eliminated. In this state, the illness can
be delayed for several years, contributing to the patho-
genesis of HBV-GN.
The present study revealed that the degree of glom-
eruli damage was different in patients with different
serum HBV infection markers. The serum HBV infec-
tion markers were predominantly HBsAg, HBeAg and
anti-HBc and HBsAg, anti-HBe and anti-HBc, which
were related to the severity of urine protein leakage.
The pathological type of HBV-GN as determined by
renal biopsy was most frequently MsPGN, followed by
MPGN. The pathological subtypes of patients with ele-
vated BUN and Scr levels were MsPGN and MPGN. This
result was different from that of previous studies that
have shown that the most common histological type was







V <15 5(1.5)parallels the geographic patterns of HBV prevalence, with
marked differences in the epidemiology of HBV infection
among continents and regions. Lu et al. reported that
HBV S gene mutations were closely associated with
HBV-GN. However, HBV serotype or genotype charac-
teristics differ between areas; the serotype ayw and geno-
type A of HBV are predominant in HBV-GN in South
Africa, while the endemic HBV strains are serotype adw
and genotype B in south China, and serotype adr and
genotype C in Korea [19]. However, the effects of these
differences on the pathological subtype composition and
syndrome of HBV-GN remains unclear. There have been
no further worldwide reports of HBV-GN since the re-
port by Levy and Chen [20] in the 1980s, until now. The
current data based on over one hundred million people
in Northeast China will provide a useful basis for further
investigations into HBV-GN.
HBsAg and HBcAg were deposited in the glomeruli of
50% of the patients with the MsPGN subtype of HBV-
GN, and HBsAg and HBcAg were deposited in theFigure 4 The relationship between the renal function stage and
hepatitis serum markers in the 329 cases. The staging of renal
function revealed that most patients were in stage I. The
proportions of patients with glomerulus damage resulting from HBV
infection were 68.39% (225/329) in stage I.
Table 7 Moderate-severe decrease of GFR and the
pathological subtype of HBV-GN
Pathological subtype Renal function staging, number (%)
III IV V Total
MsPGN 6 2 0 8(21.1)*
MPGN 6 5 1 12(31.6)*
MN 0 1 0 1
MCG 0 0 1 1
GML 2 0 1 3
IgAN 3 1 0 4
other 6 1 2 9
total 23 10 5 38
Figure 5 The distribution of different pathological subtype with diffe
quantitatively detection of urine protein, renal function were easily damage
and Anti-HBc positive and HBsAg, Anti-HBe and Anti-HBc positive in serum
patients with elevated BUN and Scr were MsPGN and MPGN (*P < 0.05).
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spectively. With respect to the renal function staging of
the 329 cases, most patients with HBV-GN were in stage
I (68.3%), and this condition was ignored by patients or
doctors. Once the GFR has changed substantially, the
kidneys have been irreversibly damaged. Thus, the detec-
tion of HBsAg and HBcAg in glomeruli of patients with
HBV infection can predict the severity of the disease.
In general, the prognosis mainly depends on the patho-
logical subtype. In this study, the prognosis of HBV-GN
ranged from spontaneous remission to renal failure. The
MPGN and MsPGN subtypes of HBV-GN represented
over half (52.7%) of the 38 cases in GFR stages III-V.
Patients with the minimal glomerulonephritis subtype ofrent urine protein and elevated BUN and Scr. 5A: In the
d in patients with MPGN and MsPGN; 5B: Patients with HBsAg, HBeAg
were prone to leak out urine protein. 5C: The pathological subtype of











HBsAg+, HBcAg- 49 29(59.2) 29(59.2) 26(53.1) 22(44.9)
HBsAg-, HBcAg+ 64 49(76.6) 44(68.8) 42(65.6) 22(34.4)
HBsAg+, HBcAg+ 122 89(73) 84(68.9) 96(78.7) 58(47.5)
HBsAg-, HBcAg- 94 64(68.1) 64(68.1) 67(71.3) 43(45.7)
Total 329 231 221 231 145
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nign prognosis; those patients with the MsPGN subtype
have a poor prognosis, and those with the MPGN sub-
type have the worst prognosis. Patients with MsPGN and
MPGN can advance to chronic renal function failure.
Most patients with HBV-GN were male. Patients aged
from 30 to 39 years old had the highest incidence of
HBV-GN. Their initial symptom was edema, in agree-
ment with another study [13]. The deposits of HBsAg,
HBcAg, and simple HBcAg increased with the increase
in the levels of deposits of IgA, IgG, IgM and C3 in the
glomeruli. At present, the process from the onset and
aggravation of HBV-GN to renal function failure is
closely related to the quantity of HBsAg, HbcAg, im-
mune globulin deposits and the pathological subtype.
Conclusion
The study found that the most common pathological sub-
type in HBV-GN was MsPGN, and serological HBsAg-,
HBeAg- and anti-HBc-positive patients was easy to de-
velop MPGN. HBsAg and HBcAg were mainly deposited
in the glomeruli of MsPGN and MPGN patients. In
addition, cases with a moderate to severe decrease in the
GFR were predominantly patients with MPGN or
MsPGN. Patients who were serological HBsAg, HBeAg
and anti-HBc positive or HBsAg, anti-HBe and anti-HBc
positive mostly exhibited urine and renal parameter
changes. Thus, clinicians should use HBV markers to
judge renal disease in the early stages when it is reversible.
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